International Biotechnology Trust (IBT)
Category Sector Equity Biotechnology
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
980.00p
Buy
992.00p
16.00p (+1.64%)
Discount/Premium
-6.00%
Estimated NAV
1,053.228p
Prices updated at 12 Dec 2025, 16:43 GMT
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- News & dates
- Trust info
- Director info
Portfolio as of 30/09/2025
Asset allocation
Show long & short position
Geographical breakdown
Continent or country allocation (%)
Market classification (%)
Top 10 holdings
1
Scb Sholo211123b 22-May-2025 5.41% 23-Jun-2025
Sector
-
Country
-
% of assets
12.37146
2
Madrigal Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.90057
3
Avidity Biosciences Inc Ordinary Shares
Sector
-
Country
United States
% of assets
4.87701
4
Vera Therapeutics Inc Class A
Sector
-
Country
United States
% of assets
4.51438
5
Regeneron Pharmaceuticals Inc
Sector
-
Country
United States
% of assets
4.40992
6
Ascendis Pharma AS ADR
Sector
-
Country
Denmark
% of assets
4.16907
7
Akero Therapeutics Inc
Sector
-
Country
United States
% of assets
4.16105
8
Sv Bcof
Sector
-
Country
-
% of assets
3.97703
9
Sv Fund Vi Investment
Sector
-
Country
-
% of assets
3.48179
10
Soleno Therapeutics Inc
Sector
-
Country
United States
% of assets
2.8264
Assets in top 10 holdings %
49.69%
Total no. of equity holdings
75.00
Total no. of bond holdings
1.00
Stock sectors
International Biotechnology Trust
Sector Equity Biotechnology
0.00%
Basic materials
Con cyclical
Financial svs
Real estate
0.00%
Comm services
Energy
Industrials
Technology
100.00%
Con defensive
Healthcare
Utilities
